NASDAQ OMX GlobeNewswire

A Step Closer for Zemprocitinib: Here's the Lowdown Surprise in the pharma skies as Lynk Pharmaceuticals takes a major leap with its new gem, zemprocitinib, entering the regulatory review phase. The center buzzed on November 4 when China's NMPA gave the coveted nod to this New Drug Application (NDA). Seems the race for rheumatoid arthritis (RA) treatments just got a...

SuperCom's Financial Report: What's on the Horizon? It's not every day that a company rolls out its financial results with expectations as layered as a lasagna, especially when you're talking about a player as entangled in IoT and cybersecurity as SuperCom. They're planning to drop their third quarter 2026 financials on November 12. It's a date for the calendar because,...

Securities Trouble on the Horizon: IRTC Takes a Hit Wake up and adjust your seat, folks—iRhythm Technologies (NASDAQ:IRTC) is in the spotlight, and it ain't pretty. Shares nosedived over 30% in a single morning, stirring up quite the murky waters for shareholders. The trigger? A less-than-stellar third-quarter report. The Numbers Don't Lie—Or Do They? Management...

Something about the first chill in the air can spark that holiday vibe, and Lands' End sure knows how to bottle it. They’ve concocted a hefty dose of festive magic in Chicago with their weekend shindig, a mix of holiday nostalgia, community cheer, and retail bravado. Now, I'm not here to just wax poetic about winter hats and fuzzy pajamas, but this event's got a twinkle...

We're watching the countdown to November 19, 2026, when Kuaishou Technology plans to spill the beans on its third-quarter earnings. Now, the clock's ticking not just in Beijing but across the financial landscape, as investors everywhere hold their breaths, hoping for some juicy financial insights from this colossal social platform. It's a heavyweight showdown any stock...

Championing a Legacy of Compassion in Medicine Listen up: not every day you hear about someone leading healthcare with a soul. Here's Dr. Lachlan Forrow, celebrated by the Albert Schweitzer Fellowship for shaping bioethics and medical humanism for over forty years. This fella's carved out a niche that melds heart with healthcare, and that's why he's scoring the inaugural...

New Era for Crunch Fitness in Jurupa Valley When you've been around the block as much as some of us have, you learn to spot the makings of a solid investment. Fitness Ventures isn't just tossing another gym into the sea of treadmills and barbells; they're making waves with their new $5 million Crunch 3.0 club in Jurupa Valley. This isn't some half-baked, pop-up fitness...

Shifting Legislative Sands for Business Giddy up, folks! The political tectonic plates just shifted with Democrats grabbing the reins of Congress. For businesses trying to keep their heads above water or score a victory lap, this change could mean adjusting to new winds blowing from Capitol Hill. What could this Democratic majority spell out for taxes, tariffs, and...

Breaking New Ground with Founders Grove It’s not every day a community gets a new lease on life through bricks and mortar, but Milton Hershey School (MHS) just did exactly that. They've broken ground on Founders Grove, a piece of the Hershey West End development puzzle that reflects both history and future potential. This isn’t just another housing project—this...

Where Did It All Go Wrong for Tenax? They say the stock market is a rollercoaster, but Tenax Therapeutics, Inc. (NASDAQ: TENX) seems to have taken that expression way too literally. Imagine watching your investments tumble by nearly 90% in a single day. On August 10, 2026, that was the grim reality for Tenax's stockholders when the company's shares plummeted from over $13...